SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001047469-18-006183
Filing Date
2018-09-13
Accepted
2018-09-13 08:04:58
Documents
8
Effectiveness Date
2018-09-13

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2236666zs-3asr.htm S-3ASR 131018
2 EX-5.1 a2236666zex-5_1.htm EX-5.1 21343
3 EX-12.1 a2236666zex-12_1.htm EX-12.1 64970
4 EX-23.1 a2236666zex-23_1.htm EX-23.1 2573
5 EX-25.1 a2236666zex-25_1.htm EX-25.1 68297
6 G271292LA03I001.GIF g271292la03i001.gif GRAPHIC 50488
7 G271292LA03I002.JPG g271292la03i002.jpg GRAPHIC 49490
8 G773827.JPG g773827.jpg GRAPHIC 23390
  Complete submission text file 0001047469-18-006183.txt   459478
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-227316 | Film No.: 181067969
SIC: 2834 Pharmaceutical Preparations